Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.

The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ (2009) 3.43

Impact of normalization on miRNA microarray expression profiling. RNA (2009) 2.63

Novel functions for small RNA molecules. Curr Opin Mol Ther (2009) 1.39

Functional microRNA involved in endometriosis. Mol Endocrinol (2011) 1.36

MicroRNA expression in human airway smooth muscle cells: role of miR-25 in regulation of airway smooth muscle phenotype. Am J Respir Cell Mol Biol (2009) 1.36

miRNAs and estrogen action. Trends Endocrinol Metab (2012) 1.24

Estrogen Regulation of MicroRNA Expression. Curr Genomics (2009) 1.20

Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis. J Biol Chem (2010) 1.18

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res (2012) 1.14

The role of microRNAs in ovarian cancer initiation and progression. J Cell Mol Med (2010) 1.08

Sex differences in microRNA regulation of gene expression: no smoke, just miRs. Biol Sex Differ (2012) 1.08

Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas. PLoS One (2010) 1.05

Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One (2012) 1.00

Retracted microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol Hum Reprod (2009) 0.97

The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Mol Cell Endocrinol (2011) 0.97

Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway. Proc Natl Acad Sci U S A (2013) 0.96

Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype. J Ovarian Res (2008) 0.95

Estrogen receptor-mediated regulation of microRNA inhibits proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2012) 0.94

miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol (2015) 0.94

Minireview: The roles of small RNA pathways in reproductive medicine. Mol Endocrinol (2011) 0.92

Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer. Mol Cell Endocrinol (2012) 0.92

Role of Dicer in female fertility. Trends Endocrinol Metab (2009) 0.92

miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol (2012) 0.91

The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma. Semin Reprod Med (2008) 0.90

MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone. PLoS One (2011) 0.88

Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop. Fertil Steril (2011) 0.88

MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2. J Cancer Res Clin Oncol (2015) 0.87

An emerging role for microRNAs in sexually dimorphic neurobiological systems. Pflugers Arch (2013) 0.86

An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma. J Transl Med (2012) 0.84

Epigenetic dysregulation in laryngeal squamous cell carcinoma. J Oncol (2012) 0.83

Hormonal regulation of microRNA expression in steroid producing cells of the ovary, testis and adrenal gland. PLoS One (2013) 0.83

MicroRNA-23a participates in estrogen deficiency induced gap junction remodeling of rats by targeting GJA1. Int J Biol Sci (2015) 0.82

MicroRNA Regulation of Smooth Muscle Phenotype. Mol Cell Pharmacol (2012) 0.82

Integrated analysis of long noncoding RNAs and mRNAs reveals their potential roles in the pathogenesis of uterine leiomyomas. Oncotarget (2014) 0.82

Role of microRNA-21 and programmed cell death 4 in the pathogenesis of human uterine leiomyomas. Fertil Steril (2012) 0.81

Challenges for MicroRNA Microarray Data Analysis. Microarrays (Basel) (2013) 0.80

5-Hydroxymethylcytosine promotes proliferation of human uterine leiomyoma: a biological link to a new epigenetic modification in benign tumors. J Clin Endocrinol Metab (2014) 0.79

An Empirical Evaluation of Normalization Methods for MicroRNA Arrays in a Liposarcoma Study. Cancer Inform (2013) 0.79

Effect of luteal-phase support on endometrial microRNA expression following controlled ovarian stimulation. Reprod Biol Endocrinol (2012) 0.79

MicroRNA expression in Epstein-Barr virus-associated post-transplant smooth muscle tumours is related to leiomyomatous phenotype. Clin Sarcoma Res (2013) 0.79

microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report. Tumour Biol (2013) 0.78

Detection of 1α,25-dihydroxyvitamin D-regulated miRNAs in zebrafish by whole transcriptome sequencing. Zebrafish (2014) 0.78

Non-coding RNAs in Uterine Development, Function and Disease. Adv Exp Med Biol (2016) 0.77

Progesterone receptor action in leiomyoma and endometrial cancer. Prog Mol Biol Transl Sci (2009) 0.77

TGFβ1 attenuates expression of prolactin and IGFBP-1 in decidualized endometrial stromal cells by both SMAD-dependent and SMAD-independent pathways. PLoS One (2010) 0.77

Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomas. Cancer Lett (2013) 0.76

MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyoma. Reprod Biol Endocrinol (2016) 0.75

microRNAs and the adolescent brain: Filling the knowledge gap. Neurosci Biobehav Rev (2016) 0.75

Retracted: differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med (2015) 0.75

Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci Rep (2017) 0.75

Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production. Fertil Steril (2016) 0.75

Plasma microRNAs in ovarian cancer--response. Clin Cancer Res (2013) 0.75

MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59

The functions of animal microRNAs. Nature (2004) 64.85

MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29

A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09

MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05

Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics (2002) 20.59

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res (2005) 18.58

Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res (2003) 17.13

miR-21-mediated tumor growth. Oncogene (2006) 9.90

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology (2006) 7.06

MicroRNA expression and function in cancer. Trends Mol Med (2006) 7.02

MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol (2006) 5.40

An E2F/miR-20a autoregulatory feedback loop. J Biol Chem (2006) 5.20

MicroRNA function: multiple mechanisms for a tiny RNA? RNA (2005) 4.78

Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem (2006) 4.57

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene (2007) 4.46

The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol (2006) 4.31

Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene (2006) 3.51

The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol (2007) 3.39

Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril (2003) 2.89

miRNAs and apoptosis: RNAs to die for. Oncogene (2006) 2.80

Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun (2006) 2.65

Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res (2006) 2.59

Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril (2002) 2.48

MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene (2006) 2.47

A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer (2007) 2.35

Principles of micro-RNA production and maturation. Oncogene (2006) 2.27

Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol (2005) 2.18

Analyzing micro-RNA expression using microarrays. Methods Enzymol (2006) 1.68

Ten-year review of hysterectomy morbidity and mortality: can we change direction? Aust N Z J Obstet Gynaecol (2001) 1.63

Genome-wide microRNA profiling in human fetal nervous tissues by oligonucleotide microarray. Childs Nerv Syst (2006) 1.34

Systematic review of mifepristone for the treatment of uterine leiomyomata. Obstet Gynecol (2004) 1.33

Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology (2004) 1.31

Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer (2004) 1.30

Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig (2006) 1.27

In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol Hum Reprod (2006) 1.19

Leiomyomata: heritability and cytogenetic studies. Hum Reprod Update (2001) 1.19

Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig (2003) 1.13

Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod (2002) 1.13

Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil Steril (2001) 1.07

Genomic and proteomic profiling I: leiomyomas in African Americans and Caucasians. Reprod Biol Endocrinol (2007) 1.04

Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Endocrinology (2004) 0.95

Characterization of messenger RNA expression of estrogen receptor-alpha and -beta in patients with ovarian endometriosis. Fertil Steril (2000) 0.94

Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Hum Reprod (2002) 0.91

Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril (2006) 0.89

Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids (2006) 0.88

Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy. Steroids (2003) 0.87

Retracted The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod (2007) 2.18

STAT1 and STAT3 alpha/beta splice form activation predicts host responses in mouse hepatitis virus type 3 infection. J Med Virol (2003) 1.58

Retracted Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells. Reprod Biol Endocrinol (2003) 1.46

Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci (2010) 1.45

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia. Obstet Gynecol (2020) 1.38

Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology (2004) 1.31

Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol (2009) 1.25

MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med (2008) 1.20

Circulating chemokine levels and miscarriage. Am J Epidemiol (2007) 1.19

Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig (2003) 1.13

Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. Reprod Sci (2012) 1.11

Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant (2003) 1.11

Circulating levels of cytokines during pregnancy: thrombopoietin is elevated in miscarriage. Fertil Steril (2007) 1.07

The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol (2003) 1.05

Genomic and proteomic profiling I: leiomyomas in African Americans and Caucasians. Reprod Biol Endocrinol (2007) 1.04

Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab (2004) 1.03

Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3. J Clin Endocrinol Metab (2012) 1.00

Retracted The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci (2008) 1.00

Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int (2002) 0.99

Retracted microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol Hum Reprod (2009) 0.97

Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Endocrinology (2004) 0.95

Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling. Mol Hum Reprod (2005) 0.95

Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther (2006) 0.94

Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection. J Immunol (2005) 0.93

CXCR2 blockade reduces radical formation in hyperoxia-exposed newborn rat lung. Pediatr Res (2006) 0.92

Potential regulatory functions of microRNAs in the ovary. Semin Reprod Med (2008) 0.91

miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol (2012) 0.91

miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Endocr Relat Cancer (2012) 0.90

The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma. Semin Reprod Med (2008) 0.90

Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol (2003) 0.89

Automatic bone age assessment based on intelligent algorithms and comparison with TW3 method. Comput Med Imaging Graph (2008) 0.89

Retracted The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-beta. J Clin Endocrinol Metab (2003) 0.89

Genomic and proteomic profiling II: comparative assessment of gene expression profiles in leiomyomas, keloids, and surgically-induced scars. Reprod Biol Endocrinol (2007) 0.88

Retracted Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog. J Clin Endocrinol Metab (2003) 0.88

Retracted CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells. Mol Hum Reprod (2006) 0.87

Neonatal neutrophils with prolonged survival secrete mediators associated with chronic inflammation. Neonatology (2010) 0.87

Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins. PLoS One (2008) 0.87

Downregulating SOCS3 with siRNA ameliorates insulin signaling and glucose metabolism in hepatocytes of IUGR rats with catch-up growth. Pediatr Res (2012) 0.87

Hepoxilin analogs inhibit bleomycin-induced pulmonary fibrosis in the mouse. J Pharmacol Exp Ther (2002) 0.87

Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int (2012) 0.87

Maternal serum granulocyte colony-stimulating factor levels and spontaneous preterm birth. J Womens Health (Larchmt) (2009) 0.86

Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells. Am J Physiol Endocrinol Metab (2004) 0.86

Retracted Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleeding. Hum Reprod (2006) 0.85

Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J Biol Chem (2008) 0.84

Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther (2010) 0.84

The effects of bilirubin on evoked potentials and long-term potentiation in rat hippocampus in vivo. Pediatr Res (2003) 0.84

MicroRNA-34a inhibits human brain glioma cell growth by down-regulation of Notch1. J Huazhong Univ Sci Technolog Med Sci (2012) 0.84

Retracted Normosmic idiopathic hypogonadotropic hypogonadism: update on the genetic background and future challenges. J Pediatr Endocrinol Metab (2013) 0.83

Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors. Pharmacotherapy (2006) 0.83

ISPAD Clinical Practice Consensus Guidelines 2014. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes (2014) 0.83

Fibroblast growth factor receptor-1 and neonatal compensatory lung growth after exposure to 95% oxygen. Am J Respir Crit Care Med (2003) 0.81

Effects of targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated shRNA and excessive intake of lysine on apoptosis in rat striatal neurons. PLoS One (2013) 0.81

KCTD9 contributes to liver injury through NK cell activation during hepatitis B virus-induced acute-on-chronic liver failure. Clin Immunol (2013) 0.81

Differential expression of interleukins IL-13 and IL-15 in normal ovarian tissue and ovarian carcinomas. Gynecol Oncol (2004) 0.80

Histological characteristics and altered expression of interleukins (IL) IL-13 and IL-15 in endometria of levonorgestrel users with different uterine bleeding patterns. Fertil Steril (2005) 0.80

Liver TCRγδ(+) CD3(+) CD4(-) CD8(-) T cells contribute to murine hepatitis virus strain 3-induced hepatic injury through a TNF-α-dependent pathway. Mol Immunol (2012) 0.79

Macrophages as a major source of oxygen radicals in the hyperoxic newborn rat lung. Free Radic Biol Med (2003) 0.79

The influence of down-regulation of suppressor of cellular signaling proteins by RNAi on glucose transport of intrauterine growth retardation rats. Pediatr Res (2011) 0.79

Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-alpha and TGF-beta in human endometrial epithelial and stromal cells. Mol Hum Reprod (2005) 0.78

[Fulminant viral hepatitis: mice model and its clinical implications]. Zhonghua Gan Zang Bing Za Zhi (2002) 0.78

A Chinese patient with acquired partial lipodystrophy caused by a novel mutation with LMNB2 gene. J Pediatr Endocrinol Metab (2012) 0.78

Increased expression of interferon-inducible protein-10 during surgically induced peritoneal injury. Wound Repair Regen (2003) 0.78

Combined adenovirus-mediated artificial microRNAs targeting mfgl2, mFas, and mTNFR1 protect against fulminant hepatic failure in mice. PLoS One (2013) 0.78

Growth hormone and treatment outcomes: expert review of current clinical practice. Pediatr Endocrinol Rev (2011) 0.77

Negative regulation of virus-triggered IFN-beta signaling pathway by alternative splicing of TBK1. J Biol Chem (2008) 0.77

CD4-CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation. Cell Immunol (2012) 0.77

Bond degradation behavior of self-adhesive cement and conventional resin cements bonded to silanized ceramic. J Prosthet Dent (2011) 0.77

Transient elastography in hepatitis B virus infection. Liver stiffness discrepancy due to sampling location. Saudi Med J (2014) 0.77

Effects of retinoic acid on the expressions of Vangl1 and vangl2 in mouse fetuses. J Neurogenet (2008) 0.77

Efficacy of subcutaneous administration of gonadotropin-releasing hormone agonist on idiopathic central precocious puberty. J Huazhong Univ Sci Technolog Med Sci (2006) 0.77

The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta. Hum Reprod (2006) 0.76

Caspase-3 mediates apoptosis of striatal cells in GA I rat model. J Huazhong Univ Sci Technolog Med Sci (2012) 0.76

The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. J Biochem (2008) 0.76

Localization and cellular distribution of pregnancy-associated plasma protein-a and major basic protein in human ovary and corpora lutea throughout the menstrual cycle. Fertil Steril (2003) 0.76

The effect of interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) on granulocyte macrophage-colony stimulating factor (GM-CSF) production by neuronal precursor cells. Eur Cytokine Netw (2002) 0.76

Comparative evaluation of short-term biomarker response to treatment for growth hormone deficiency in Chinese children with growth hormone deficiency born small for or appropriate for gestational age: a randomized phase IV open-label study. Ther Adv Endocrinol Metab (2013) 0.75

Effect of siloxane quantity and ph of silane coupling agents and contact angle of resin bonding agent on bond durability of resin cements to machinable ceramic. J Adhes Dent (2011) 0.75

Identification of compound heterozygous mutations in GNPTG in three siblings of a Chinese family with mucolipidosis type III gamma. Mol Genet Metab (2010) 0.75

Construction of plasmids expressing Sars-CoV encoding proteins and their effects on transcription of hfgl2 prothrombinase. J Huazhong Univ Sci Technolog Med Sci (2009) 0.75

Clinical characteristics and gene mutation analysis of methylmalonic aciduria. J Huazhong Univ Sci Technolog Med Sci (2011) 0.75

Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathways. Biol Chem (2016) 0.75

Protection of INS-1 cells from free fatty acid-induced apoptosis by inhibiting the glycogen synthase kinase-3. J Huazhong Univ Sci Technolog Med Sci (2007) 0.75